DCVC, founded in 2010 and based in Palo Alto, California, is a venture capital firm that invests in seed and early-stage companies across various sectors, including artificial intelligence, exascale computing, climate, engineering, materials science, robotics, space, water, biology, defense, security, and deep tech. The firm leverages a unique team of experienced venture capitalists, technology entrepreneurs, and practicing engineers, bringing together over 35 technology executives and experts from prestigious institutions. DCVC also operates a dedicated fund, DCVC Bio, which focuses on early-stage startups in computational biology, aiming to harness advancements in genetic sequencing, artificial intelligence, and automation to drive innovation in synthetic biology, medicine, and agriculture. With a proven track record of over 150 companies and 40 material exits, DCVC is committed to fostering deep technological changes that enhance life sciences and IT infrastructure.